Literature DB >> 15517671

Bulking agents for stress urinary incontinence: short-term results and complications in a randomized comparison of periurethral and transurethral injections.

Jane A Schulz1, Charles W Nager, Stuart L Stanton, Kaven Baessler.   

Abstract

The purpose of our study was to compare the two standard routes of urethral bulking injection in a prospective randomized trial. Forty women with genuine stress incontinence (n = 36), or mixed incontinence with a minor and controlled urge component (n = 4), participated in a urethral bulking agent trial. All patients had a standardized preoperative evaluation which included history, physical examination, assignment of incontinence status on a Stamey grading scale, postvoid residual (PVR) determination, Valsalva leak-point pressure, maximal urethral closure pressure, functional urethral length, Q-tip excursion angle, quantitative pad test, and completion of a quality of life questionnaire. On the day of injection they were randomly assigned to a periurethral or transurethral route of injection based on a computer-generated block randomization scheme. An ultrasound-determined PVR was obtained on all patients after injection. If self-catheterization was necessary, and the PVR was > 200 ml, urinary retention was diagnosed. Postoperative assessment included a patient interview, subjective assessment of improvement, PVR, voiding diary, and assignment of incontinence grade. At the screening visit there were no significant differences between the groups for any variables except type of stress incontinence. With short-term follow-up both transurethral and periurethral routes of injection seem to be equally efficacious. In the periurethral injection group there was a higher rate of postoperative retention; this group had a significantly higher volume of injectable agent used. There was no significant difference in risk of urinary tract infections between the two groups. We conclude that both periurethral and transurethral methods of bulking agent injection for stress urinary incontinence are equally efficacious, with minimal morbidity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517671     DOI: 10.1007/s00192-004-1148-6

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  8 in total

Review 1.  The use of periurethral injectables in the treatment of genuine stress incontinence.

Authors:  J R Duckett
Journal:  Br J Obstet Gynaecol       Date:  1998-04

2.  Diagnosing intrinsic sphincteric deficiency: comparing urethral closure pressure, urethral axis, and Valsalva leak point pressures.

Authors:  R C Bump; K W Coates; G W Cundiff; R L Harris; A C Weidner
Journal:  Am J Obstet Gynecol       Date:  1997-08       Impact factor: 8.661

3.  The urethral pressure profile.

Authors:  M Brown; J E Wickham
Journal:  Br J Urol       Date:  1969-04

4.  Periurethral collagen injection: a long-term follow-up study.

Authors:  E Gorton; S Stanton; A Monga; A K Wiskind; G M Lentz; D R Bland
Journal:  BJU Int       Date:  1999-12       Impact factor: 5.588

5.  Periurethral collagen injection for stress incontinence with and without urethral hypermobility.

Authors:  A C Steele; N Kohli; M M Karram
Journal:  Obstet Gynecol       Date:  2000-03       Impact factor: 7.661

6.  Comparison of transurethral versus periurethral collagen injection in women with intrinsic sphincter deficiency.

Authors:  G J Faerber; W D Belville; D A Ohl; A Plata
Journal:  Tech Urol       Date:  1998-09

7.  Endoscopic collagen injection therapy in elderly women with type I stress urinary incontinence.

Authors:  G J Faerber
Journal:  J Urol       Date:  1996-02       Impact factor: 7.450

8.  Periurethral collagen injections for genuine stress incontinence: a 2-year follow-up.

Authors:  A K Monga; D Robinson; S L Stanton
Journal:  Br J Urol       Date:  1995-08
  8 in total
  11 in total

1.  Periurethral granuloma following injection with dextranomer/hyaluronic acid copolymer for stress urinary incontinence.

Authors:  María-Teresa Castillo-Vico; Miguel A Checa-Vizcaíno; Antonio Payà-Panadés; Carolina Rueda-García; Ramón Carreras-Collado
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-12-03

2.  Combined trans- and periurethral injections of bulking agents for the treatment of intrinsic sphincter deficiency.

Authors:  Eric R Sokol; Vivian C Aguilar; Vivian W Sung; Deborah L Myers
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-10-27

Review 3.  Regenerative medicine based applications to combat stress urinary incontinence.

Authors:  Hatim Thaker; Arun K Sharma
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 4.  Urethral injection therapy for urinary incontinence in women.

Authors:  Vivienne Kirchin; Tobias Page; Phil E Keegan; Kofi Om Atiemo; June D Cody; Samuel McClinton; Patricia Aluko
Journal:  Cochrane Database Syst Rev       Date:  2017-07-25

Review 5.  Injectable biomaterials for the treatment of stress urinary incontinence: their potential and pitfalls as urethral bulking agents.

Authors:  Niall F Davis; F Kheradmand; T Creagh
Journal:  Int Urogynecol J       Date:  2012-12-08       Impact factor: 2.894

Review 6.  Outcome measures for stress urinary incontinence treatment: can we minimally agree?

Authors:  Véronique Phé; Philippe Zimmern; Emmanuel Chartier-Kastler
Journal:  World J Urol       Date:  2015-03-20       Impact factor: 4.226

7.  Quality of life after periurethral injection with polyacrylamide hydrogel for stress urinary incontinence.

Authors:  Gerda Trutnovsky; Karl Tamussino; Elfriede Greimel; Vesna Bjelic-Radisic
Journal:  Int Urogynecol J       Date:  2010-10-09       Impact factor: 2.894

Review 8.  Urethral bulking agents: techniques and outcomes.

Authors:  Ahmed F Kotb; Lysanne Campeau; Jacques Corcos
Journal:  Curr Urol Rep       Date:  2009-09       Impact factor: 3.092

Review 9.  Regenerative medicine and injection therapies in stress urinary incontinence.

Authors:  Christopher J Hillary; Sabiniano Roman; Sheila MacNeil; Wilhelm K Aicher; Arnulf Stenzl; Christopher R Chapple
Journal:  Nat Rev Urol       Date:  2020-01-23       Impact factor: 14.432

Review 10.  Stem cells for stress urinary incontinence: the adipose promise.

Authors:  Régis Roche; Franck Festy; Xavier Fritel
Journal:  J Cell Mol Med       Date:  2009-10-03       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.